Category: Markets
Published: 2026-06-30T14:17:45.000Z
The FDA has selected seven companies, including Eli Lilly and Regeneron, for its PreCheck Pilot Program. This initiative aims to accelerate the readiness of new U.S. pharmaceutical manufacturing facilities, thereby strengthening the domestic drug supply chain and improving access to critical medicines. The program offers a two-phase model providing technical guidance and earlier regulatory engagement to streamline the approval process for new production sites.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.